Search for Clinical Trial Results
Adrenocortical Carcinoma - 64 Studies Found
Status | Study |
Completed |
Study Name: Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2011-12-21 Interventions: Drug: Dovitinib Dovitinib (TKI-258), gelatin capsule of 10 |
Completed |
Study Name: Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2006-05-08 Interventions: Drug: cisplatin, taxotere cisplatin 75 mg/m2 Taxotere 75 mg/m2 |
Recruiting |
Study Name: German Adrenocortical Carcinoma Registry Condition: Adrenocortical Carcinoma Date: 2007-03-28 |
Completed |
Study Name: A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2009-06-17 Interventions:
|
Completed |
Study Name: Sunitinib in Refractory Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2007-03-28 Interventions: Drug: Sunitinib |
Completed |
Study Name: Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) Condition: Nonresectable Adrenocortical Carcinoma Date: 2005-09-15 Interventions: Drug: Iressa (ZD1839) |
Completed |
Study Name: Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2013-12-13 |
Recruiting |
Study Name: Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2016-02-01 Interventions: Drug: Pembrolizumab |
Terminated |
Study Name: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery Condition: Adrenocortical Carcinoma Date: 1999-11-01 Interventions:
|
Withdrawn |
Study Name: Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2007-05-02 Interventions: Drug: Bevacizumab |